{"id":"https://openalex.org/W1494057233","doi":"https://doi.org/10.3233/jad-140291","title":"A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia1","display_name":"A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia1","alternate_titles":[],"publication_year":2014,"publication_date":"2014-09-16","ids":{"openalex":"https://openalex.org/W1494057233","doi":"https://doi.org/10.3233/jad-140291","mag":"1494057233","pmid":"https://pubmed.ncbi.nlm.nih.gov/25024314"},"language":"en","primary_location":{"id":"doi:10.3233/jad-140291","doi":"https://doi.org/10.3233/jad-140291","is_oa":true,"landing_page_url":"https://doi.org/10.3233/jad-140291","pdf_url":"https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad140291?id=journal-of-alzheimers-disease%2Fjad140291","source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1494057233"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad140291?id=journal-of-alzheimers-disease%2Fjad140291","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056724494","display_name":"George M. Haig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George M. Haig","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034584090","display_name":"Yili Pritchett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yili Pritchett","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019132479","display_name":"Andreas Meier","orcid":"https://orcid.org/0000-0003-3669-8677","observed_orcids":["https://orcid.org/0000-0003-3669-8677"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andreas Meier","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038665116","display_name":"Ahmed A. Othman","orcid":"https://orcid.org/0000-0002-4937-2775","observed_orcids":["https://orcid.org/0000-0002-4937-2775"]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]},{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["EG","US"],"is_corresponding":false,"raw_author_name":"Ahmed A. Othman","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA","Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt","AbbVie, North Chicago, IL, USA Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]},{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455","https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048385132","display_name":"Coleen M. Hall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Coleen Hall","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036372932","display_name":"Laura M. Gault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura M. Gault","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091278189","display_name":"Robert A. Lenz","orcid":"https://orcid.org/0000-0002-0078-6598","observed_orcids":["https://orcid.org/0000-0002-0078-6598"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Lenz","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056724494"],"corresponding_institution_ids":["https://openalex.org/I2948539688"],"apc_list":null,"apc_paid":null,"fwci":3.1399,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.92716906,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"42","issue":"3","first_page":"959","last_page":"971"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.30300000309944153,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histamine-h3-receptor-antagonists","display_name":"histamine H3 receptor antagonists","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.922775387763977},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7772153615951538},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.649830162525177},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6176761388778687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5877679586410522},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5645751357078552},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5599749088287354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5458394289016724},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5409153699874878},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5362675786018372},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37292683124542236},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.22256216406822205},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08845105767250061},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06554847955703735},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054828","descriptor_name":"Histamine H3 Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D054828","descriptor_name":"Histamine H3 Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3233/jad-140291","doi":"https://doi.org/10.3233/jad-140291","is_oa":true,"landing_page_url":"https://doi.org/10.3233/jad-140291","pdf_url":"https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad140291?id=journal-of-alzheimers-disease%2Fjad140291","source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's Disease","raw_type":"journal-article"},{"id":"pmid:25024314","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25024314","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's disease : JAD","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.882.8328","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.882.8328","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://content.iospress.com/download/journal-of-alzheimers-disease/jad140291?id%3Djournal-of-alzheimers-disease/jad140291","raw_type":"text"}],"best_oa_location":{"id":"doi:10.3233/jad-140291","doi":"https://doi.org/10.3233/jad-140291","is_oa":true,"landing_page_url":"https://doi.org/10.3233/jad-140291","pdf_url":"https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad140291?id=journal-of-alzheimers-disease%2Fjad140291","source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1494057233.pdf","grobid_xml":"https://content.openalex.org/works/W1494057233.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W39805860","https://openalex.org/W1519717100","https://openalex.org/W1605886981","https://openalex.org/W1623139931","https://openalex.org/W1808821669","https://openalex.org/W1847168837","https://openalex.org/W1895538680","https://openalex.org/W1919779618","https://openalex.org/W1953027527","https://openalex.org/W1963682618","https://openalex.org/W1969793379","https://openalex.org/W1971074692","https://openalex.org/W1991517279","https://openalex.org/W1996776294","https://openalex.org/W1997262070","https://openalex.org/W2006444691","https://openalex.org/W2020212968","https://openalex.org/W2020433416","https://openalex.org/W2024719735","https://openalex.org/W2042502927","https://openalex.org/W2059393353","https://openalex.org/W2059569476","https://openalex.org/W2061409645","https://openalex.org/W2062825859","https://openalex.org/W2078896068","https://openalex.org/W2081695582","https://openalex.org/W2096162880","https://openalex.org/W2109464535","https://openalex.org/W2111963393","https://openalex.org/W2120064419","https://openalex.org/W2123200781","https://openalex.org/W2127398647","https://openalex.org/W2130900903","https://openalex.org/W2136332296","https://openalex.org/W2138883123","https://openalex.org/W2146643950","https://openalex.org/W2156220037","https://openalex.org/W2521817557","https://openalex.org/W2943352209","https://openalex.org/W4211157318"],"related_works":["https://openalex.org/W2051330983","https://openalex.org/W1988584193","https://openalex.org/W1902663605","https://openalex.org/W2122352421","https://openalex.org/W2138338009","https://openalex.org/W2147371554","https://openalex.org/W2130325529","https://openalex.org/W2534984889","https://openalex.org/W2024578724"],"abstract_inverted_index":{"BACKGROUND:":[0],"ABT-288,":[1],"a":[2,41],"highly":[3],"selective":[4],"histamine-3":[5],"receptor":[6],"antagonist,":[7],"demonstrated":[8,144],"efficacy":[9,26,89,160],"across":[10],"several":[11],"preclinical":[12],"cognitive":[13],"domains,":[14],"and":[15,20,27,45,153],"safety":[16,28],"in":[17,31,66,161],"healthy":[18],"subjects":[19,32,63],"elderly":[21],"volunteers.":[22],"OBJECTIVE:":[23],"Evaluate":[24],"the":[25,92,100,124,162],"of":[29,61,165],"ABT-288":[30,71,129,156],"with":[33,50],"mild-to-moderate":[34],"Alzheimer's":[35,102,166],"dementia.":[36,167],"METHODS:":[37],"The":[38,87,111],"study":[39,57,112],"used":[40],"randomized,":[42],"double-blind,":[43],"placebo-":[44],"active-controlled,":[46],"parallel":[47],"group":[48],"design":[49],"pre-defined":[51],"futility":[52,117],"criteria":[53,118],"to":[54,70,96,135],"permit":[55],"early":[56],"termination.":[58],"A":[59],"total":[60,108],"242":[62],"were":[64,119,132,141,150],"randomized":[65],"an":[67],"equal":[68],"ratio":[69],"1":[72],"mg":[73],"or":[74,80],"3":[75],"mg,":[76,79],"donepezil":[77],"10":[78],"placebo":[81,136],"once":[82],"daily":[83],"for":[84,127],"12":[85],"weeks.":[86],"primary":[88],"endpoint":[90],"was":[91,113],"change":[93],"from":[94],"baseline":[95],"final":[97],"evaluation":[98],"on":[99,123],"13-item":[101],"Disease":[103],"Assessment":[104],"Scale-cognitive":[105],"subscale":[106],"(ADAS-Cog)":[107],"score.":[109],"RESULTS:":[110],"prematurely":[114],"terminated":[115],"because":[116],"met.":[120],"Point":[121],"estimates":[122],"ADAS-Cog":[125],"scores":[126],"both":[128],"dose":[130],"groups":[131],"numerically":[133],"inferior":[134],"but":[137],"no":[138],"statistical":[139],"differences":[140],"detected.":[142],"Donepezil":[143],"statistically":[145],"significant":[146],"improvement.":[147],"Adverse":[148],"events":[149],"generally":[151],"mild":[152],"self-limiting.":[154],"CONCLUSION:":[155],"did":[157],"not":[158],"demonstrate":[159],"symptomatic":[163],"treatment":[164]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1494057233","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
